Neural differentiation and support of neuroregeneration of non-neural adult stem cells

Progress in Brain Research

Volumn 201, Issue , 2012, Pages 17-34

  Verfaillie, Catherine M ^a   Abraham, Rojin ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Endothelial progenitor cells; Mesenchymal stem stromal cells; Neural stem cells; Trophic factors

Indexed keywords

ACUTE HEART INFARCTION; ADIPOSE TISSUE; ADULT STEM CELL; AMNIOTIC FLUID STEM CELL; ANGIOGENESIS; ARTICLE; BONE MARROW; BONE MARROW CELL; CELL POPULATION; CEREBROVASCULAR ACCIDENT; DEGENERATIVE DISEASE; DENDRITIC CELL; ENDOTHELIAL PROGENITOR CELL; ENDOTHELIUM CELL; HEMATOPOIETIC STEM CELL; HUMAN; MARROW ISOLATED ADULT MULTILINEAGE INDUCIBLE CELL; MESENCHYMAL STEM CELL; MESENCHYMAL STROMA CELL; MULTIPOTENT ADULT PROGENITOR CELL; MULTIPTOTENT ADULT STEM CELL; NERVE CELL DIFFERENTIATION; NERVE REGENERATION; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION; TOOTH PULP; UMBILICAL CORD BLOOD; UNRESTRICTED SOMATIC STEM CELL; VERY SMALL EMBRYONIC STEM CELL LIKE CELL;

EID: 84870212030     PISSN: 00796123     EISSN: 18757855     Source Type: Book Series    
DOI: 10.1016/B978-0-444-59544-7.00002-0     Document Type: Chapter

References (113)

1. Aggarwal S., Pittenger M.F. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 2005, 105:1815-1822.
2. Alder J., Kramer B.C., Hoskin C., Thakker-Varia S. Brain-derived neurotrophic factor produced by human umbilical tissue-derived cells is required for its effect on hippocampal dendritic differentiation. Dev. Neurobiol. 2012, 72:755-765.
3. American Heart Association Heart disease and stroke statistics update: a report from the Statistics Committee and American Heart Association Stroke Statistics Subcommittee. Circulation 2009, 22:e21-e181.
4. Andrews E.M., Tsai S.Y., Johnson S.C., Farrer J.R., Wagner J.P., Kopen G.C., Kartje G.L. Human adult bone marrow-derived somatic cell therapy results in functional recovery and axonal plasticity following stroke in the rat. Exp. Neurol. 2008, 211:588-592.
5. Anjos-Afonso F., Bonnet D. Nonhematopoietic/endothelial SSEA-1+ cells define the most primitive progenitors in the adult murine bone marrow mesenchymal compartment. Blood 2007, 109:1298-1306.
6. Aranguren X.L., McCue J.D., Hendrickx B., Zhu X.H., Du F., Chen E., Pelacho B., Penuelas I., Abizanda G., Uriz M., et al. Multipotent adult progenitor cells sustain function of ischemic limbs in mice. J. Clin. Invest. 2008, 118:505-514.
7. Arslan F., Keogh B., McGuirk P., Parker A.E. TLR2 and TLR4 in ischemia reperfusion injury. Mediators Inflamm. 2011, 2010:704202.
8. Arvidsson A., Collin T., Kirik D., Kokaia Z., Lindvall O. Neuronal replacement from endogenous precursors in the adult brain after stroke. Nat. Med. 2002, 8:963-970.
9. Asahara T., Takahashi T., Masuda H., Kalka C., Chen D., Iwaguro H., Inai Y., Silver M., Isner J. VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J. 1999, 18:3964-3972.
10. Atlasi Y., Mowla S.J., Ziaee S.A., Gokhale P.J., Andrews P.W. OCT4 spliced variants are differentially expressed in human pluripotent and nonpluripotent cells. Stem Cells 2008, 26:3068-3074.
11. Augello A., Tasso R., Negrini S.M., Amateis A., Indiveri F., Cancedda R., Pennesi G. Bone marrow mesenchymal progenitor cells inhibit lymphocyte proliferation by activation of the programmed death 1 pathway. Eur. J. Immunol. 2005, 35:1482-1490.
12. Bacigaluppi M., Pluchino S., Peruzzotti-Jametti L., Kilic E., Kilic U., Salani G., Brambilla E., West M.J., Comi G., Martino G., et al. Delayed post-ischaemic neuroprotection following systemic neural stem cell transplantation involves multiple mechanisms. Brain 2009, 132:2239-2251.
13. Balasubramaniam V., Ryan S.L., Seedorf G.J., Roth E.V., Heumann T.R., Yoder M.C., Ingram D.A., Hogan C.J., Markham N.E., Abman S.H. Bone marrow-derived angiogenic cells restore lung alveolar and vascular structure after neonatal hyperoxia in infant mice. Am. J. Physiol. Lung Cell. Mol. Physiol. 2010, 298:L315-L323.
14. Bao X., Wei J., Feng M., Lu S., Li G., Dou W., Ma W., Ma S., An Y., Qin C., et al. Transplantation of human bone marrow-derived mesenchymal stem cells promotes behavioral recovery and endogenous neurogenesis after cerebral ischemia in rats. Brain Res. 2011, 1367:103-113.
15. Beltrami A.P., Cesselli D., Bergamin N., Marcon P., Rigo S., Puppato E., D'Aurizio F., Verardo R., Piazza S., Pignatelli A., et al. Multipotent cells can be generated in vitro from several adult human organs (heart, liver and bone marrow). Blood 2007, 110:3438-3446.
16. Bieback K., Hecker A., Kocaomer A., Lannert H., Schallmoser K., Strunk D., Kluter H. Human alternatives to fetal bovine serum for the expansion of mesenchymal stromal cells from bone marrow. Stem Cells 2009, 27:2331-2341.
17. Boiani M., Kehler J., Scholer H.R. Activity of the germline-specific Oct4-GFP transgene in normal and clone mouse embryos. Methods Mol. Biol. 2004, 254:1-34.
18. Booth H.A., Holland P.W. Eleven daughters of NANOG. Genomics 2004, 84:229-238.
19. Boquest A.C., Shahdadfar A., Fronsdal K., Sigurjonsson O., Tunheim S.H., Collas P., Brinchmann J.E. Isolation and transcription profiling of purified uncultured human stromal stem cells: alteration of gene expression after in vitro cell culture. Mol. Biol. Cell 2005, 16:1131-1141.
20. Bork S., Pfister S., Witt H., Horn P., Korn B., Ho A.D., Wagner W. DNA methylation pattern changes upon long-term culture and aging of human mesenchymal stromal cells. Aging Cell 2010, 9:54-63.
21. Bramlett H.M., Dietrich W.D. Pathophysiology of cerebral ischemia and brain trauma: similarities and differences. J. Cereb. Blood Flow Metab. 2004, 24:133-150.
22. Cantz T., Key G., Bleidissel M., Gentile L., Han D.W., Brenne A., Scholer H.R. Absence of OCT4 expression in somatic tumor cell lines. Stem Cells 2008, 26:692-697.
23. Caplan A.I. Mesenchymal stem cells. J. Orthop. Res. 1991, 9:641-650.
24. Caplan A.I. Adult mesenchymal stem cells for tissue engineering versus regenerative medicine. J. Cell. Physiol. 2007, 213:341-347.
25. Chen J., Shehadah A., Pal A., Zacharek A., Cui X., Cui Y., Roberts C., Lu M., Zeitlin A., Hariri R., et al. Neuroprotective effect of human placenta-derived cell treatment of stroke in rats. Cell Transplant. 2012, Mar 28. [Epub ahead of print].
26. Coyne T.M., Akiva J.M., Woodbury D., Black I.B. Marrow stromal cells transplanted to the adult brain are rejected by an inflammatory response and transfer donor labels to host neurons and glia. Stem Cells 2006, 24(11):2483-2492. Epub 2006 Jul 27.
27. Deng M., Daley G.Q. Expression of interferon consensus sequence binding protein induces potent immunity against BCR/ABL-induced leukemia. Blood 2001, 97:3491-3497.
28. Deng Y.B., Ye W.B., Hu Z.Z., Yan Y., Wang Y., Takon B.F., Zhou G.Q., Zhou Y.F. Intravenously administered BMSCs reduce neuronal apoptosis and promote neuronal proliferation through the release of VEGF after stroke in rats. Neurol. Res. 2011, 32:148-156.
29. Di Nicola M., Carlo-Stella C., Magni M., Milanesi M., Longoni P.D., Matteucci P., Grisanti S., Gianni A.M. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 2002, 99:3838-3843.
30. D'Ippolito G., Diabira S., Howard G.A., Menei P., Roos B.A., Schiller P.C. Marrow-isolated adult multilineage inducible (MIAMI) cells, a unique population of postnatal young and old human cells with extensive expansion and differentiation potential. J. Cell Sci. 2004, 117:2971-2981.
31. Dirnagl U., Iadecola C., Moskowitz M.A. Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci. 1999, 22:391-397.
32. Dominici M., Le Blanc K., Mueller I., Slaper-Cortenbach I., Marini F., Krause D., Deans R., Keating A., Prockop D., Horwitz E. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006, 8:315-317.
33. Droetto S., Viale A., Primo L., Jordaney N., Bruno S., Pagano M., Piacibello W., Bussolino F., Aglietta M. Vasculogenic potential of long term repopulating cord blood progenitors. FASEB J. 2004, 18:1273-1275.
34. Ekdahl C.T., Kokaia Z., Lindvall O. Brain inflammation and adult neurogenesis: the dual role of microglia. Neuroscience 2009, 158:1021-1029.
35. Englund U., Bjorklund A., Wictorin K., Lindvall O., Kokaia M. Grafted neural stem cells develop into functional pyramidal neurons and integrate into host cortical circuitry. Proc. Natl. Acad. Sci. U.S.A. 2002, 99:17089-17094.
36. Fairbanks D.J., Maughan P.J. Evolution of the NANOG pseudogene family in the human and chimpanzee genomes. BMC Evol. Biol. 2006, 6:12.
37. Fan Y., Shen F., Frenzel T., Zhu W., Ye J., Liu J., Chen Y., Su H., Young W.L., Yang G.Y. Endothelial progenitor cell transplantation improves long-term stroke outcome in mice. Ann. Neurol. 2011, 67:488-497.
38. Fujiwara Y., Tanaka N., Ishida O., Fujimoto Y., Murakami T., Kajihara H., Yasunaga Y., Ochi M. Intravenously injected neural progenitor cells of transgenic rats can migrate to the injured spinal cord and differentiate into neurons, astrocytes and oligodendrocytes. Neurosci. Lett. 2004, 366:287-291.
39. Gage F.H. Mammalian neural stem cells. Science 2000, 287:1433-1438.
40. Gao J., Dennis J.E., Muzic R.F., Lundberg M., Caplan A.I. The dynamic in vivo distribution of bone marrow-derived mesenchymal stem cells after infusion. Cells Tissues Organs 2001, 169:12-20.
41. Gee J.M., Kalil A., Shea C., Becker K.J. Lymphocytes: potential mediators of postischemic injury and neuroprotection. Stroke 2007, 38:783-788.
42. Giraldi-Guimaraes A., Rezende-Lima M., Bruno F.P., Mendez-Otero R. Treatment with bone marrow mononuclear cells induces functional recovery and decreases neurodegeneration after sensorimotor cortical ischemia in rats. Brain Res. 2009, Feb 9. [Epub ahead of print].
43. Hayakawa K., Qiu J., Lo E.H. Biphasic actions of HMGB1 signaling in inflammation and recovery after stroke. Ann. N. Y. Acad. Sci. 2011, 1207:50-57.
44. Hendrickx B., Verdonck K., Van den Berge S., Dickens S., Eriksson E., Vranckx J.J., Luttun A. Integration of blood outgrowth endothelial cells in dermal fibroblast sheets promotes full thickness wound healing. Stem Cells 2010, 28:1165-1177.
45. Hess D.C., Hill W.D., Martin-Studdard A., Carothers J., Brailer J., Carroll J. Blood into brain after stroke. Trends Mol. Med. 2002, 8:452-453.
46. Hess D.C., Hill W.D., Martin-Studdard A., Carroll J., Brailer J., Carothers J. Bone marrow as a source of endothelial cells and NeuN-expressing cells after stroke. Stroke 2002, 33:1362-1368.
47. Holzwarth C., Vaegler M., Gieseke F., Pfister S.M., Handgretinger R., Kerst G., Muller I. Low physiologic oxygen tensions reduce proliferation and differentiation of human multipotent mesenchymal stromal cells. BMC Cell Biol. 2010, 11:11.
48. Honma T., Honmou O., Iihoshi S., Harada K., Houkin K., Hamada H., Kocsis J.D. Intravenous infusion of immortalized human mesenchymal stem cells protects against injury in a cerebral ischemia model in adult rat. Exp. Neurol. 2006, 199:56-66.
49. Hurn P.D., Subramanian S., Parker S.M., Afentoulis M.E., Kaler L.J., Vandenbark A.A., Offner H. T- and B-cell-deficient mice with experimental stroke have reduced lesion size and inflammation. J. Cereb. Blood Flow Metab. 2007, 27:1798-1805.
50. Ikegame Y., Yamashita K., Hayashi S., Mizuno H., Tawada M., You F., Yamada K., Tanaka Y., Egashira Y., Nakashima S., et al. Comparison of mesenchymal stem cells from adipose tissue and bone marrow for ischemic stroke therapy. Cytotherapy 2011, 13:675-685.
51. Ingram D.A., Mead L.E., Moore D.B., Woodard W., Fenoglio A., Yoder M.C. Vessel wall-derived endothelial cells rapidly proliferate because they contain a complete hierarchy of endothelial progenitor cells. Blood 2005, 105:2783-2786.
52. Kehler J., Tolkunova E., Koschorz B., Pesce M., Gentile L., Boiani M., Lomeli H., Nagy A., McLaughlin K.J., Scholer H.R., et al. Oct4 is required for primordial germ cell survival. EMBO Rep. 2004, 5:1078-1083.
53. Keimpema E., Fokkens M.R., Nagy Z., Agoston V., Luiten P.G., Nyakas C., Boddeke H.W., Copray J.C. Early transient presence of implanted bone marrow stem cells reduces lesion size after cerebral ischaemia in adult rats. Neuropathol. Appl. Neurobiol. 2009, 35:89-102.
54. Kelly S., Bliss T.M., Shah A.K., Sun G.H., Ma M., Foo W.C., Masel J., Yenari M.A., Weissman I.L., Uchida N., et al. Transplanted human fetal neural stem cells survive, migrate, and differentiate in ischemic rat cerebral cortex. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:11839-11844.
55. Koch P., Kokaia Z., Lindvall O., Brustle O. Emerging concepts in neural stem cell research: autologous repair and cell-based disease modelling. Lancet Neurol. 2009, 8:819-829.
56. Koh S.H., Kim K.S., Choi M.R., Jung K.H., Park K.S., Chai Y.G., Roh W., Hwang S.J., Ko H.J., Huh Y.M., et al. Implantation of human umbilical cord-derived mesenchymal stem cells as a neuroprotective therapy for ischemic stroke in rats. Brain Res. 2008, 1229:233-248.
57. Kong Y., Le Y. Toll-like receptors in inflammation of the central nervous system. Int. Immunopharmacol. 2011, 11:1407-1414.
58. Kopen G., Prockop D., Phinney D. Marrow stromal cells migrate throughout forebrain and cerebellum, and they differentiate into astrocytes after injection into neonatal mouse brains. Proc. Natl. Acad. Sci. U.S.A. 1999, 96:10711-10716.
59. Krampera M., Glennie S., Dyson J., Scott D., Laylor R., Simpson E., Dazzi F. Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide. Blood 2003, 101:3722-3729.
60. Krampera M., Cosmi L., Angeli R., Pasini A., Liotta F., Andreini A., Santarlasci V., Mazzinghi B., Pizzolo G., Vinante F., et al. Role for interferon-gamma in the immunomodulatory activity of human bone marrow mesenchymal stem cells. Stem Cells 2006, 24:386-398.
61. Kucia M., Halasa M., Wysoczynski M., Baskiewicz-Masiuk M., Moldenhawer S., Zuba-Surma E., Czajka R., Wojakowski W., Machalinski B., Ratajczak M.Z. Morphological and molecular characterization of novel population of CXCR4+ SSEA-4+ Oct-4+ very small embryonic-like cells purified from human cord blood: preliminary report. Leukemia 2007, 21:297-303.
62. Kucia M., Wysoczynski M., Ratajczak J., Ratajczak M.Z. Identification of very small embryonic like (VSEL) stem cells in bone marrow. Cell Tissue Res. 2008, 331:125-134.
63. Le Blanc K., Tammik L., Sundberg B., Haynesworth S.E., Ringden O. Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex. Scand. J. Immunol. 2003, 57:11-20.
64. Lee J.P., Jeyakumar M., Gonzalez R., Takahashi H., Lee P.J., Baek R.C., Clark D., Rose H., Fu G., Clarke J., et al. Stem cells act through multiple mechanisms to benefit mice with neurodegenerative metabolic disease. Nat. Med. 2007, 13:439-447.
65. Lengner C.J., Camargo F.D., Hochedlinger K., Welstead G.G., Zaidi S., Gokhale S., Scholer H.R., Tomilin A., Jaenisch R. Oct4 expression is not required for mouse somatic stem cell self-renewal. Cell Stem Cell 2007, 1:403-415.
66. Leu S., Lin Y.C., Yuen C.M., Yen C.H., Kao Y.H., Sun C.K., Yip H.K. Adipose-derived mesenchymal stem cells markedly attenuate brain infarct size and improve neurological function in rats. J. Transl. Med. 2011, 8:63.
67. Li S., Waer M., Billiau A.D. Xenotransplantation: role of natural immunity. Transpl. Immunol. 2009, 21:70-74.
68. Liao W., Xie J., Zhong J., Liu Y., Du L., Zhou B., Xu J., Liu P., Yang S., Wang J., et al. Therapeutic effect of human umbilical cord multipotent mesenchymal stromal cells in a rat model of stroke. Transplantation 2009, 87:350-359.
69. Liedtke S., Enczmann J., Waclawczyk S., Wernet P., Kogler G. Oct4 and its pseudogenes confuse stem cell research. Cell Stem Cell 2007, 1:364-366.
70. Lin Y., Weisdorf D.J., Solovey A., Hebbel R.P. Origins of circulating endothelial cells and endothelial outgrowth from blood. J. Clin. Invest. 2000, 105:71-77.
71. Maccario R., Podesta M., Moretta A., Cometa A., Comoli P., Montagna D., Daudt L., Ibatici A., Piaggio G., Pozzi S., et al. Interaction of human mesenchymal stem cells with cells involved in alloantigen-specific immune response favors the differentiation of CD4+ T-cell subsets expressing a regulatory/suppressive phenotype. Haematologica 2005, 90:516-525.
72. Madinier A., Bertrand N., Mossiat C., Prigent-Tessier A., Beley A., Marie C., Garnier P. Microglial involvement in neuroplastic changes following focal brain ischemia in rats. PLoS One 2009, 4:e8101.
73. Maroso M., Balosso S., Ravizza T., Liu J., Bianchi M.E., Vezzani A. Interleukin-1 type 1 receptor/Toll-like receptor signalling in epilepsy: the importance of IL-1beta and high-mobility group box 1. J. Intern. Med. 2011, 270:319-326.
74. Meisel C., Meisel A. Suppressing immunosuppression after stroke. N. Engl. J. Med. 2012, 365:2134-2136.
75. Mezey E., Key S., Vogelsang G., Szalayova I., Lange G.D., Crain B. Transplanted bone marrow generates new neurons in human brains. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:1364-1369.
76. Minatoguchi S. Granulocyte colony stimulating factor, peripheral blood stem cells and bone marrow stem cells for cardiac repair after myocardial infarction. Circ. J. 2011, 75:789-790.
77. Moisan A., Pannetier N., Grillon E., Richard M.J., de Fraipont F., Remy C., Barbier E.L., Detante O. Intracerebral injection of human mesenchymal stem cells impacts cerebral microvasculature after experimental stroke: MRI study. NMR Biomed. 2012, Apr 27. [Epub ahead of print]. 10.1002/nbm.2806.
78. Moubarik C., Guillet B., Youssef B., Codaccioni J.L., Piercecchi M.D., Sabatier F., Lionel P., Dou L., Foucault-Bertaud A., Velly L., et al. Transplanted late outgrowth endothelial progenitor cells as cell therapy product for stroke. Stem Cell Rev. 2011, 7:208-220.
79. Nakamura K., Tsurushima H., Marushima A., Nagano M., Yamashita T., Suzuki K., Ohneda O., Matsumura A. A subpopulation of endothelial progenitor cells with low aldehyde dehydrogenase activity attenuates acute ischemic brain injury in rats. Biochem. Biophys. Res. Commun. 2011, 418:87-92.
80. Nauta A.J., Fibbe W.E. Immunomodulatory properties of mesenchymal stromal cells. Blood 2007, 110:3499-3506.
81. Nomura T., Honmou O., Harada K., Houkin K., Hamada H., Kocsis J.D. I.V. infusion of brain-derived neurotrophic factor gene-modified human mesenchymal stem cells protects against injury in a cerebral ischemia model in adult rat. Neuroscience 2005, 136:161-169.
82. Ourednik J., Ourednik V., Lynch W.P., Schachner M., Snyder E.Y. Neural stem cells display an inherent mechanism for rescuing dysfunctional neurons. Nat. Biotechnol. 2002, 20:1103-1110.
83. Park K.I., Teng Y.D., Snyder E.Y. The injured brain interacts reciprocally with neural stem cells supported by scaffolds to reconstitute lost tissue. Nat. Biotechnol. 2002, 20:1111-1117.
84. Passier R., van Laake L.W., Mummery C.L. Stem-cell-based therapy and lessons from the heart. Nature 2008, 453:322-329.
85. Pavlichenko N., Sokolova I., Vijde S., Shvedova E., Alexandrov G., Krouglyakov P., Fedotova O., Gilerovich E.G., Polyntsev D.G., Otellin V.A. Mesenchymal stem cells transplantation could be beneficial for treatment of experimental ischemic stroke in rats. Brain Res. 2008, 1233:203-213.
86. Planas A.M., Chamorro A. Regulatory T cells protect the brain after stroke. Nat. Med. 2009, 15:138-139.
87. Pluchino S., Zanotti L., Rossi B., Brambilla E., Ottoboni L., Salani G., et al. Neurosphere-derived multipotent precursors promote neuroprotection by an immunomodulatory mechanism. Nature 2005, 436:266-271.
88. Ramos-Cabrer P., Justicia C., Wiedermann D., Hoehn M. Stem cell mediation of functional recovery after stroke in the rat. PLoS One 2010, 5:e12779.
89. Rehman J., Li J., Orschell C.M., March K.L. Peripheral blood " endothelial progenitor cells" are derived from monocyte/macrophages and secrete angiogenic growth factors. Circulation 2003, 107:1164-1169.
90. Roobrouck V., Clavel Claver C., Jacobs S.A., Ulloa-Montoya F., Crippa S., Sohni A., Roberts S., Luyten F.P., Van Gool S., Sampaolesi M., et al. Differentiation potential of human postnatal MSC, MAB and MAPC reflected in their transcriptome and partially influenced by the culture conditions. Stem Cells 2011, 29(5):871-882. 10.1002/stem.633.
91. Roobrouck V.D., Vanuytsel K., Verfaillie C.M. Concise review: culture mediated changes in fate and/or potency of stem cells. Stem Cells 2011, 29:583-589.
92. Sacchetti B., Funari A., Michienzi S., Di Cesare S., Piersanti S., Saggio I., Tagliafico E., Ferrari S., Robey P.G., Riminucci M., et al. Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment. Cell 2007, 131:324-336.
93. Sanchez M., Secades L., Bordallo C., Meana C., Rubin J.M., Cantabrana B., Bordallo J. Role of polyamines and cAMP-dependent mechanisms on 5alpha-dihydrotestosterone-elicited functional effects in isolated right atria of rat. J. Cardiovasc. Pharmacol. 2009, 54:310-318.
94. Scheibe F., Ladhoff J., Huck J., Grohmann M., Blazej K., Oersal A., Baeva N., Seifert M., Priller J. Immune effects of mesenchymal stromal cells in experimental stroke. J. Cereb. Blood Flow Metab. 2012, 32(8):1578-1588. Epub 2012 May 2. 10.1038/jcbfm.2012.55.
95. Schmidt-Lucke C., Rossig L., Fichtlscherer S., Vasa M., Britten M., Kamper U., Dimmeler S., Zeiher A.M. Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair. Circulation 2005, 111:2981-2987.
96. Sieveking D.P., Buckle A., Celermajer D.S., Ng M.K. Strikingly different angiogenic properties of endothelial progenitor cell subpopulations: insights from a novel human angiogenesis assay. J. Am. Coll. Cardiol. 2008, 51:660-668.
97. Sozen T., Tsuchiyama R., Hasegawa Y., Suzuki H., Jadhav V., Nishizawa S., Zhang J.H. Role of interleukin-1beta in early brain injury after subarachnoid hemorrhage in mice. Stroke 2009, 40:2519-2525.
98. Spaggiari G.M., Capobianco A., Abdelrazik H., Becchetti F., Mingari M.C., Moretta L. Mesenchymal stem cells inhibit natural killer-cell proliferation, cytotoxicity, and cytokine production: role of indoleamine 2,3-dioxygenase and prostaglandin E2. Blood 2008, 111:1327-1333.
99. Steiner B., Roch M., Holtkamp N., Kurtz A. Systemically administered human bone marrow-derived mesenchymal stem home into peripheral organs but do not induce neuroprotective effects in the MCAo-mouse model for cerebral ischemia. Neurosci. Lett. 2012, 513:25-30.
100. Sugiyama M., Iohara K., Wakita H., Hattori H., Ueda M., Matsushita K., Nakashima M. Dental pulp-derived CD31(-)/CD146(-) side population stem/progenitor cells enhance recovery of focal cerebral ischemia in rats. Tissue Eng. Part A 2011, 17:1303-1311.
101. Trakhtenberg E.F., Goldberg J.L. Immunology. Neuroimmune communication. Science 2012, 334:47-48.
102. Uccelli A., Moretta L., Pistoia V. Mesenchymal stem cells in health and disease. Nat. Rev. Immunol. 2008, 8:726-736.
103. Voulgari-Kokota A., Fairless R., Karamita M., Kyrargyri V., Tseveleki V., Evangelidou M., Delorme B., Charbord P., Diem R., Probert L. Mesenchymal stem cells protect CNS neurons against glutamate excitotoxicity by inhibiting glutamate receptor expression and function. Exp. Neurol. 2012, 236(1):161-170. Epub 2012 Apr 25.
104. Wagner J., Kean T., Young R., Dennis J.E., Caplan A.I. Optimizing mesenchymal stem cell-based therapeutics. Curr. Opin. Biotechnol. 2009, 20:531-536.
105. Wakabayashi K., Nagai A., Sheikh A.M., Shiota Y., Narantuya D., Watanabe T., Masuda J., Kobayashi S., Kim S.U., Yamaguchi S. Transplantation of human mesenchymal stem cells promotes functional improvement and increased expression of neurotrophic factors in a rat focal cerebral ischemia model. J. Neurosci. Res. 2011, 88:1017-1025.
106. Wang Q., Tang X.N., Yenari M.A. The inflammatory response in stroke. J. Neuroimmunol. 2007, 184:53-68.
107. Yang Y.C., Liu B.S., Shen C.C., Lin C.H., Chiao M.T., Cheng H.C. Transplantation of adipose tissue-derived stem cells for treatment of focal cerebral ischemia. Curr. Neurovasc. Res. 2011, 8:1-13.
108. Yang K.L., Lee J.T., Pang C.Y., Lee T.Y., Chen S.P., Liew H.K., Chen S.Y., Chen T.Y., Lin P.Y. Human adipose-derived stem cells for the treatment bof intracerebral hemorrhage in rats via femoral intravenous injection. Cell. Mol. Biol. Lett. 2012, 17(3):376-392. Epub 2012 Apr 28.
109. Yoder M.C., Mead L.E., Prater D., Krier T.R., Mroueh K.N., Li F., Krasich R., Temm C.J., Prchal J.T., Ingram D.A. Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals. Blood 2007, 109:1801-1809.
110. Yoo S.W., Kim S.S., Lee S.Y., Lee H.S., Kim H.S., Lee Y.D., Suh-Kim H. Mesenchymal stem cells promote proliferation of endogenous neural stem cells and survival of newborn cells in a rat stroke model. Exp. Mol. Med. 2008, 40:387-397.
111. Zentilin L., Tafuro S., Zacchigna S., Arsic N., Pattarini L., Sinigaglia M., Giacca M. Bone marrow mononuclear cells are recruited to the sites of VEGF-induced neovascularization but are not incorporated into the newly formed vessels. Blood 2006, 107:3546-3554.
112. Zhao L.R., Duan W.M., Reyes M., Keene C.D., Verfaillie C.M., Low W.C. Human bone marrow stem cells exhibit neural phenotypes and ameliorate neurological deficits after grafting into the ischemic brain of rats. Exp. Neurol. 2002, 174:11-20.
113. Zuk P.A. The intracellular distribution of the ES cell totipotent markers OCT4 and Sox2 in adult stem cells differs dramatically according to commercial antibody used. J. Cell. Biochem. 2009, 106:867-877.